AREVA logo

2016 1st Quarter Revenue

Press release

April 28, 2016

At March 31, 2016:

Backlog of €33.6 bn (vs. €29 bn end of 2015)
Revenue of €826 m: -0.8% vs. March 2015
(-2.2% like for like) due in particular to a less favorable schedule of uranium deliveries than in the 1st quarter of 2015
• Operations held for sale (including AREVA NP):
     
o Backlog of €13.9 bn (vs. €13.8 bn end of 2015)
      o Revenue of €885 m: -4.8% vs. March 2015

Implementation of the performance plan:
       o During the 1st quarter, close to 700 new departures recorded in the group, in line with the target of 6,000 people by the end of 2017
       o Proposals from suppliers following the convention of December 2015 held to consolidate the supply chain component

 

 

-----------------------------------------------
1 Restated for IFRS 5
2 Includes the Corporate, AREVA Med, Bioenergy operations and the OL3 project

Contact